Cargando…

A Novel Mechanism of Regulation for Exosome Secretion in the Diabetic Kidney

Detalles Bibliográficos
Autores principales:	Feng, Ye, Liu, Bicheng, Lee, Kyung, He, John Cijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336009/ https://www.ncbi.nlm.nih.gov/pubmed/34155044 http://dx.doi.org/10.2337/dbi21-0015

Ejemplares similares

Mechanisms and treatment of COVID-19-associated acute kidney injury
por: Zhou, Weibin, et al.
Publicado: (2023)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

The Role of SIRT1 in Diabetic Kidney Disease
por: Yacoub, Rabi, et al.
Publicado: (2014)

SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2018)

Cortactin enhances exosome secretion without altering cargo
por: Gangoda, Lahiru, et al.
Publicado: (2016)

Aged glomeruli: a link between PD-1 and podocytes
por: Yu, Samuel Mon-Wei, et al.
Publicado: (2022)

Fractalkine signaling in regulation of insulin secretion: Mechanisms and potential therapeutic implications?
por: Gregg, Brigid, et al.
Publicado: (2014)

Relationship between Macrophages and Tissue Microenvironments in Diabetic Kidneys
por: Yan, Jiayi, et al.
Publicado: (2023)

Editorial: Cell Cross-talk in Diabetic Kidney Diseases
por: Hong, Quan, et al.
Publicado: (2022)

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
por: Nugent, Melinda M., et al.
Publicado: (2015)

Exosomes in Diabetic Cardiomyopathy: The Next-Generation Therapeutic Targets?
por: Sahoo, Susmita, et al.
Publicado: (2016)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

Regenerating the injured kidney with human umbilical cord mesenchymal stem cell-derived exosomes
por: Dorronsoro, Akaitz, et al.
Publicado: (2013)

Regulating Glucagon Secretion: Somatostatin in the Spotlight
por: Rutter, Guy A.
Publicado: (2009)

Proximal Tubular Secretion: A New Way to Assess for Kidney Dysfunction?
por: Au, Eric H.K., et al.
Publicado: (2022)

Novel mechanism of impaired metabolism‐secretion coupling in β‐cells: Loss of cytosolic adenosine triphosphate by leakage
por: Fujimoto, Shimpei
Publicado: (2019)

Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
por: Terker, Andrew S., et al.
Publicado: (2021)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2018)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

Loss of Pulsatile Insulin Secretion: A Factor in the Pathogenesis of Type 2 Diabetes?
por: Wahren, John, et al.
Publicado: (2012)

Hypothalamic Regulation of Glucose-Stimulated Insulin Secretion
por: Chan, Owen, et al.
Publicado: (2012)

Hypothalamic AMP-activated Kinase Regulates Glucose-stimulated Insulin Secretion
por: Koh, Eun Hee, et al.
Publicado: (2016)

Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide‐binding protein Gi subunit alpha‐1 (Gnai1) subunit
por: Zhu, Qingqing, et al.
Publicado: (2022)

Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
por: Fan, Ying, et al.
Publicado: (2019)

Peeling the onion: another layer in the regulation of insulin secretion
por: Aamodt, Kristie I., et al.
Publicado: (2023)

Erratum. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes 2019;68:2301–2314
por: Fan, Ying, et al.
Publicado: (2020)

COVID-19 Acute Kidney Injury: Current Knowledge and Barriers of Research
por: Zhong, Yifei, et al.
Publicado: (2021)

Exosomal lncRNAs from mesenchymal stem cells as the novel modulators to cardiovascular disease
por: Huang, Ying
Publicado: (2020)

Role of Transcription Factor Acetylation in Diabetic Kidney Disease
por: Liu, Ruijie, et al.
Publicado: (2014)

The Discordance Between the Renal Histopathology and Clinical Presentation of Diabetic Nephropathy Calls for Novel Approaches for the Prediction and Monitoring of Kidney Failure in Diabetes
por: Østergaard, Jakob A., et al.
Publicado: (2021)

On exosome functional role in cancer: miR-494 complex regulation in melanoma cells and corresponding exosomes
por: Bellenghi, Maria, et al.
Publicado: (2019)

Exosomes in Diabetic Kidney Disease
por: Wen, Jin, et al.
Publicado: (2023)

Beyond the Glomerulus—Kidney Tubule Markers and Diabetic Kidney Disease Progression
por: Bullen, Alexander L., et al.
Publicado: (2021)

Diabetic Kidney Disease: The “Silent” Majority?
por: Yau, Amy, et al.
Publicado: (2021)

Dual therapy and diabetic kidney disease
por: Desai, T.
Publicado: (2015)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
por: Kim, Min Kyung, et al.
Publicado: (2021)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
por: Watts, Gerald F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6439sbmemop3skga3apfhev80l